— Know what they know.
Not Investment Advice

SGHT NASDAQ

Sight Sciences, Inc.
1W: +4.8% 1M: -2.6% 3M: +69.1% YTD: +20.7% 1Y: +71.0% 3Y: +145.4% 5Y: -60.9%
$9.03
+0.01 (+0.11%)
 
Weekly Expected Move ±8.7%
$7 $8 $9 $10 $11
NASDAQ · Healthcare · Medical - Devices · Tech Score Neutral · Power 58 · $497.4M mcap · 36M float · 0.729% daily turnover · Short 47% of daily vol
Credit Risk of going bust: higher than 64% of companies Debt: 7.8% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.14 (down 98%), Sight Sciences, Inc. would be worth roughly what it owes.
Total debt $42.0M against a stock market value of $497.4M.
Distance to default 3.93 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $25.5M (short-term plus half of long-term), stock volatility 75.0%; Altman Z 1.27. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$115M -19.3% ▼
5Y CAGR: +9.6%
Total Liabilities
$51M -7.2% ▼
5Y CAGR: -20.5%
Shareholders Equity
$64M -26.9% ▼
Cash & Investments
$92M -23.6% ▼
5Y CAGR: +8.4%
Total Debt
$41M +1.0% ▲
5Y CAGR: +4.7%
Net Debt
-$51M +36.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$261M$185M$138M$120M$92M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$261M$185M$138M$120M$92M
Net Receivables$9M$15M$14M$11M$10M
Inventory$3M$6M$8M$6M$8M
Other Current Assets$0$3M$3M$2M$3M
Total Current Assets$277M$210M$163M$140M$113M
Property, Plant & Equip.$3M$3M$3M$3M$2M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$202K$211K$682K$550K$518K
Total Non-Current Assets$3M$3M$4M$3M$3M
Total Assets$280M$213M$167M$143M$115M
— Liabilities —
Accounts Payable$3M$3M$2M$2M$1M
Short-Term Debt$0$0$2M$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$6M$7M$5M$10M$9M
Total Current Liabilities$14M$18M$12M$15M$11M
Long-Term Debt$33M$33M$32M$39M$40M
Other Non-Current Liab.$879K$1M$2M$19K$31K
Total Non-Current Liabilities$35M$35M$34M$40M$40M
Total Liabilities$48M$53M$46M$55M$51M
— Equity —
Common Stock$48K$48K$49K$51K$54K
Retained Earnings-$153M-$239M-$295M-$346M-$385M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$232M$160M$120M$88M$64M
Total Liabilities & Equity$280M$213M$167M$143M$115M
— Key Metrics —
Total Debt$34M$35M$35M$40M$41M
Net Debt-$226M-$150M-$103M-$80M-$51M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms